1. Home
  2. MTSR vs MGRC Comparison

MTSR vs MGRC Comparison

Compare MTSR & MGRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MTSR
  • MGRC
  • Stock Information
  • Founded
  • MTSR 2022
  • MGRC 1979
  • Country
  • MTSR United States
  • MGRC United States
  • Employees
  • MTSR N/A
  • MGRC N/A
  • Industry
  • MTSR
  • MGRC Diversified Commercial Services
  • Sector
  • MTSR
  • MGRC Consumer Discretionary
  • Exchange
  • MTSR NYSE
  • MGRC Nasdaq
  • Market Cap
  • MTSR 3.0B
  • MGRC 2.8B
  • IPO Year
  • MTSR 2025
  • MGRC N/A
  • Fundamental
  • Price
  • MTSR $29.60
  • MGRC $111.73
  • Analyst Decision
  • MTSR Strong Buy
  • MGRC Buy
  • Analyst Count
  • MTSR 6
  • MGRC 2
  • Target Price
  • MTSR $55.25
  • MGRC $145.50
  • AVG Volume (30 Days)
  • MTSR 1.0M
  • MGRC 134.7K
  • Earning Date
  • MTSR 05-12-2025
  • MGRC 07-24-2025
  • Dividend Yield
  • MTSR N/A
  • MGRC 1.74%
  • EPS Growth
  • MTSR N/A
  • MGRC 88.16
  • EPS
  • MTSR N/A
  • MGRC 9.65
  • Revenue
  • MTSR N/A
  • MGRC $918,531,000.00
  • Revenue This Year
  • MTSR N/A
  • MGRC $6.11
  • Revenue Next Year
  • MTSR N/A
  • MGRC $5.52
  • P/E Ratio
  • MTSR N/A
  • MGRC $11.58
  • Revenue Growth
  • MTSR N/A
  • MGRC 7.31
  • 52 Week Low
  • MTSR $12.30
  • MGRC $95.50
  • 52 Week High
  • MTSR $37.99
  • MGRC $129.93
  • Technical
  • Relative Strength Index (RSI)
  • MTSR N/A
  • MGRC 49.24
  • Support Level
  • MTSR N/A
  • MGRC $111.40
  • Resistance Level
  • MTSR N/A
  • MGRC $118.53
  • Average True Range (ATR)
  • MTSR 0.00
  • MGRC 2.56
  • MACD
  • MTSR 0.00
  • MGRC -0.43
  • Stochastic Oscillator
  • MTSR 0.00
  • MGRC 28.12

About MTSR METSERA INC

Metsera Inc is a clinical-stage biotechnology company developing next-generation injectable and oral nutrient-stimulated hormone (NuSH) analog peptides to treat obesity, overweight, and related conditions. The Company has developed and is implementing proprietary methods and platform technologies to advance a broad, scalable, and combinable portfolio of injectable and oral NuSH analog peptides with the potential to address not only the limitations of approved therapies but also many of the anticipated limitations of next-generation therapies in development. The Company uses its proprietary MINT peptide library of NuSH analog peptides alongside its Half-life Augmentation by Lipid Optimization half-life extending platform.

About MGRC McGrath RentCorp

McGrath RentCorp is a rental company. It is comprised of four reportable business segments namely Modular building segment (Mobile Modular); Portable storage container segment (Portable Storage); Electronic test equipment segment (TRS-RenTelco); and its classroom manufacturing business selling modular buildings used primarily as classrooms in California (Enviroplex). The company generates its revenues majorily from the rental of its equipment on operating leases with sales of equipment occurring in the normal course of business.

Share on Social Networks: